EMEvelin Melekh

Evelin Melekh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Evelin Melekh has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Can you run from your worries? The effects of exercise on anxiety-like behavior and immune signaling in female and male mice

    by Madeleine Gene Maheu, Julia Mazur, Evelin Melekh, Madeleine King, Gurprince Attlas, Emma L. Cook, Sarah Bellaflor, Sunny F. Qureshi, Ahmad Mohammad, Shawn M. Beaudette, et al.

    Our work highlights the contrast between anxiogenic and anxiolytic effects of acute vs. chronic exercise, respectively, in healthy mice. Acute and chronic exercise differentially affected circulating and brain cytokines, providing insight into physiological adaptations to exercise. Both sexes demonstrated similar cytokine responses to exercise. These similarities are novel with respect to exercise research and noteworthy given sex differences in anxiety with respect to acute exercise.

  • Open Access

    Metabolic Shifts Precede Cognitive Decline in the Male hAß‐KI Alzheimer's Mouse Model

    by Evelin Melekh, Emma L. Cook, Julia G. Stante, Amélie A. T. Marais, Ahmad Mohammad, Shawn M. Beaudette, Wendy E. Ward, Val A. Fajardo, Rebecca E. K. MacPherson

    A major barrier in AD research is the lack of animals that recapitulate sporadic AD, which accounts for most human cases. Recently, a novel mouse model (hAβ‐KI) was developed by introducing a three‐point mutation that humanizes the beta‐amyloid peptide. These mice exhibit age‐dependent cognitive decline and beta‐amyloid accumulation. However, limited research has been conducted related to AD risk factors and sex‐specific responses in this model. Male and female control and hAß‐KI mice were assessed at ages 4, 8, 10, 12 and 15 months. Body composition (bone mineral density, lean and fat mass) and metabolic function (respiratory exchange rate, energy expenditure, and activity levels) were evaluated, in addition to insulin tolerance testing (ITT). An open field test (OFT) was performed to evaluate anxiety‐like behaviors, and novel object location (NOLT) and recognition tests (NORT) were conducted to measure cognitive impairment at endpoint. With aging, the male hAß‐KI mice exhibited increased body and fat mass %, decreased lean mass %, decreased activity, and impaired glucose handling prior to confirmed cognitive impairment by NORT and NOLT. In contrast, the female hAß‐KI did not display similar differences compared to controls. These findings support the utility of this model as a valuable tool for investigating systemic risk factors related to sporadic AD, and the absence of similar differences in the females highlights the importance of considering sex as a variable in AD pathology.


  • Running toward brain health: How aerobic capacity and liver metabolism shape Alzheimer's pathology

    by Evelin Melekh, Madeleine King, Julia G. Stante, Emma L. Cook, Grace Sargeant, Sarah Bellaflor


  • Open Access

    Examining Student Perceptions and Awareness of Social Prescribing in a Canadian University

    by Alison Smoke, Stephanie Wadge, Allayna Barrett, Sophia Nikitin, Evelin Melekh, Madelyn Law, Caitlin Muhl

    Introduction: As the social prescribing movement grows in Canada, there is a need to understand whether students (a) are aware of this concept and (b) think it is important. Objectives: The aim of this study was to examine student perceptions and awareness of social prescribing in a Canadian university. Methods: This study was conducted at Brock University. Data collection took place between March and June of 2023. Eligibility criteria included (a) being a student at Brock University and (b) being able to read and write English. Participants completed an online survey. Quantitative data analysis consisted of basic mathematical computations. Qualitative data analysis consisted of qualitative content analysis. Results: Most participants (138/183, 75.4%) had never heard about social prescribing before. Once they were told what social prescribing is, the vast majority of participants thought that it seemed like a useful way to support health and well-being (121/126, 96.0%), felt that offering it on campus would be beneficial (129/130, 99.2%), believed that it is relevant to future health care professionals (121/128, 94.5%), thought that it should be part of the curriculum for health sciences programs (118/128, 92.2%), and expressed that they would be willing to follow their physician’s advice if they were to suggest social prescribing at an appointment (119/126, 94.4%). Conclusion/Discussion: Given the lack of awareness about social prescribing and the positive perceptions about this concept among the student body, Canadian post-secondary institutions are encouraged to (a) integrate this concept into the curriculum for health sciences programs and (b) offer social prescribing on campus.


  • Open Access

    Immunotherapy targeting isoDGR‐protein damage extends lifespan in a mouse model of protein deamidation

    by Pazhanichamy Kalailingam, Khalilatul‐Hanisah Mohd‐Kahliab, SoFong Cam Ngan, Ranjith Iyappan, Evelin Melekh, Tian Lu, Gan Wei Zien, Bhargy Sharma, Tiannan Guo, Adam J MacNeil, et al.

    Aging results from the accumulation of molecular damage that impairs normal biochemical processes. We previously reported that age‐linked damage to amino acid sequence NGR (Asn‐Gly‐Arg) results in “gain‐of‐function” conformational switching to isoDGR (isoAsp‐Gly‐Arg). This integrin‐binding motif activates leukocytes and promotes chronic inflammation, which are characteristic features of age‐linked cardiovascular disorders. We now report that anti‐isoDGR immunotherapy mitigates lifespan reduction of Pcmt1 −/− mouse. We observed extensive accumulation of isoDGR and inflammatory cytokine expression in multiple tissues from Pcmt1 −/− and naturally aged WT animals, which could also be induced via injection of isoDGR‐modified plasma proteins or synthetic peptides into young WT animals. However, weekly injection of anti‐isoDGR mAb (1 mg/kg) was sufficient to significantly reduce isoDGR‐protein levels in body tissues, decreased pro‐inflammatory cytokine concentrations in blood plasma, improved cognition/coordination metrics, and extended the average lifespan of Pcmt1 −/− mice. Mechanistically, isoDGR‐mAb mediated immune clearance of damaged isoDGR‐proteins via antibody‐dependent cellular phagocytosis (ADCP). These results indicate that immunotherapy targeting age‐linked protein damage may represent an effective intervention strategy in a range of human degenerative disorders.